A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
Aydin Onac has been suspended from his role at St Olave's Grammar School in Orpington.
Leaders of the Aslef union are recommending that their members accept the deal.
All inspirational people who have shown courage and kindness in the most difficult of circumstances.